MAP3K8 antibody (AA 414-445)
Quick Overview for MAP3K8 antibody (AA 414-445) (ABIN1841365)
Target
See all MAP3K8 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 414-445
-
Specificity
- This COT (MAP3K8/MEKK8) antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 414-445 amino acids from the C-terminal region of human COT (MAP3K8/MEKK8).
-
Purification
- Ammonium sulfate precipitation
-
-
-
-
Application Notes
- Approved: IHC, IHC-P (1:50 - 1:100), WB (1:1000)
-
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, 0.09 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.
-
Expiry Date
- 6 months
-
-
- MAP3K8 (Mitogen-Activated Protein Kinase Kinase Kinase 8 (MAP3K8))
-
Alternative Name
- MAP3K8 / TPL2
-
Background
-
Name/Gene ID: MAP3K8
Subfamily: MAP3K
Family: Protein Kinase
Synonyms: MAP3K8, C-COT, Cancer Osaka thyroid oncogene, COT, Ewing sarcoma transformant, EST, MEKK8, Proto-oncogene c-Cot, TPL2, Tumor progression locus 2, Protein kinase cot, Tpl-2, ESTF -
Gene ID
- 1326
-
UniProt
- P41279
-
Pathways
- PI3K-Akt Signaling, TCR Signaling
Target
-